Hepatobiliary clearance of labelled mebrofenin in normal and D-galactosamine HCl-induced hepatitis rats and the protective effect of turmeric extract

Indian Journal of Physiology and Pharmacology

Volumn 47, Issue 3, 2003, Pages 332-336

  Deshpande, U R ^a   Joseph, L J ^a   Samuel, A M ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

(GalN); 99mTc Mebrofenin; D galactosamine; Hepatic excretion; Hepatic uptake; Turmeric extract

Indexed keywords

CURCUMA LONGA EXTRACT; GALACTOSAMINE; HYDROCHLORIC ACID; MEBROFENIN TC 99M; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLEARANCE; CONTROLLED STUDY; DETOXIFICATION; HEPATITIS; HEPATOBILIARY CLEARANCE; LIVER FUNCTION; LIVER PROTECTION; MALE; NONHUMAN; RADIOACTIVITY; RAT; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILE; CURCUMA; GALACTOSAMINE; HEPATITIS, TOXIC; IMINO ACIDS; INJECTIONS, INTRAVENOUS; LIVER; LIVER FUNCTION TESTS; MALE; ORGANOTECHNETIUM COMPOUNDS; PHYTOTHERAPY; PLANT ROOTS; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 0038711363     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Jordan RA, Woolf TF. Basic concepts in drug metabolism, Part 2. J Clin Pharmacol 1987; 27: 87-90.
2. Krishnamurthy S, Krishnamurthy GT. Technetium 99m-iminodiacetic acid organic anions: review of biokinetics and clinical application in hepatology. Hepatology 1989; 9: 139-153.
3. Doo E, Krishnamurthy GT, Eklem MJ et al. Quantification of hepatobiliary function as an integral part of imaging with technetium -99m-mebrofenin in health and disease. J Nucl Med 1991; 32: 48-57.
4. Krishnamurthy GT, Turner FB. Pharmacokinetics and clinical application of technetium-99m-labeled hepatobiliary agents. Semin Nucl Med 1980; 20: 130-149.
5. Deshpande UR, Gadre SG, Raste AS et al. Protective effect of turmeric (Curcuma longa L.) extract on carbon tetrachloride induced liver damage in rats. Ind J Expt Biol 1998; 36: 573-577.
6. nd Edn. Weinheim: Verlag Chemic 1974; pp 735-739, 760-764, 860-864.
7. Bone K Turmeric-The spice of life? Brit J Phytotherapy 1991; 2: 51-60.
8. Kiso Y, Suzuki Y, Watanabe N et al. Antihepatotoxic principles of Curcuma longa rhizomes. Planta Medica 1983; 49: 185-187.
9. Decker K, Keppler D. Galactosamine hepatitis; key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol 1974; 71: 77-106.
10. Sakakibara S, Shibayama Y, Ueda I et al. The protective effect of poly H-ribocytidylic acid against the occurrence of galactosomine-induced liver cell injury in rat. Experimental 1983; 39: 174-176.
11. Frizberg AR. Advances in the development of hepatobiliary radiopharmaceuticals. In: Radiopharmaceuticals: Progress and clinical perspective Vol. 1 (Edited by Fritzberg A. R.), CRC Press, Bpca Raton. 1986; pp. 90-116.
12. Loberg MD, Cooper M Harrey E. Development of new radiopharmaceutical based on N-substitution of iminodiacetic acid. J Nucl Med 1976; 17: 633-638.
13. Subbarao D, Chandra Sekhara N, Satyanarayan MN. Effect of curcumin on serum and liver cholesterol levels in rat. J Nutr 1970; 100: 1307-1315.